Objective: To investigate the effect of Naringenin(NAR) on improving rheumatoid arthritis(RA) in model rat and its mechanism in regulating Treg/Th17 balance. Methods: Seventy-two SPF Wistar male rats were divided into control group, model group, positive group(Tripterygium wilfordii polyglycoside group), NAR low dose group, NAR medium dose group and NAR high dose group, with 12 rats in each group. The joint lesions of rats in each group were scored; the pathological changes of rat synovium were observed by hematoxylin eosin staining, and the apoptosis rates of rat synovium were detected by TUNEL method; the activity of myeloperoxidase(MPO) in rat serum was detected by the kit, the levels of rheumatoid factor(RF), C-reactive protein(CRP), interleukin-17(IL-17), transforming growth factor-β1(TGF-β1) and interleukin-10(IL-10) in serum were determined by enzyme-linked immunosorbent assay, and the expressions of retinoic acid related orphan receptor γt(RORγt) and forkhead transcription factor 3(Foxp3) protein in rat synovium were detected by Western blot. Results: Compared with the control group, the synovial tissue in the model group was obviously hyperplastic, the blood vessels in the synovium were dilated, and inflammatory cells were infiltrated more and accompanied by tissue fibrosis. The score of joint lesions, the apoptosis rate of synovial cells, the levels of MPO, RF, CRP, IL-17 and RORγt in serum increased, and the expression levels of IL-10, TGF-β1 and Foxp3 decreased(P<0.05). Compared with the model group, the synovial tissue and vascular proliferation of rats in the positive group and NAR low, medium and high dose groups decreased, the inflammatory cell infiltration was reduced, and the tissue fibrosis was not obvious. The score of joint lesions, the apoptosis rate of synovial cells, the levels of MPO, RF, CRP, IL-17 and RORγt in serum decreased, and the expression levels of IL-10, TGF-β1 and Foxp3 increased(P<0.05). Conclusion: NAR can improve RA rats by regulating Treg/Th17 balance. |
[1] LIN Y J,ANZAGHE M,SCHVLKE S.Update on the pathomechanism,diagnosis,and treatment options for rheumatoid arthritis[J].Cells,2020,9(4):880-923.
[2] YOUSSEF M E,ABDEL-REHEIM M A,MORSY M A,et al.Ameliorative effect of dabigatran on CFA-induced rheumatoid arthritis via modulating kallikrein-kinin system in rats[J].Int J Mol Sci,2022,23(18):10297-10300.
[3] LI S,WANG H,WU H,et al.Therapeutic effect of exogenous regulatory T cells on collagen-induced arthritis and rheumatoid arthritis[J].Cell Transplant,2020,29(1):1-12.
[4] GOMARIZ R P,JUARRANZ Y,CARRIÓN M,et al.An overview of VPAC receptors in rheumatoid arthritis:biological role and clinical significance[J].Front Endocrinol(Lausanne),2019,10(1):729-741.
[5] PARADOWSKA-GORYCKA A,WAJDA A,ROMANOWSKA-PRÓCHNICKA K,et al.Th17/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis[J].Front Immunol,2020,11(1):1-14.
[6] WANG Q,OU Y,HU G,et al.Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice[J].Br J Pharmacol,2020,177(8):1806-1821.
[7] HAJIZADEH A,ABTAHI-FROUSHANI S M,TEHRANI A A,et al.Effects of naringenin on experimentally induced rheumatoid arthritis in wistar rats[J].Arch Razi Inst,2021,76(4):903-912.
[8] EL SAID K S,ATTA A,MOBASHER M A,et al.Quercetin mitigates rheumatoid arthritis by inhibiting adenosine deaminase in rats[J].Mol Med,2022,28(1):24-37.
[9] 徐李玲,黄艳萍,郭殊玮,等.八角枫丸剂抗大鼠类风湿性关节炎的作用机制[J].中成药,2021,43(10):2817-2821.
[10] KHAN T H,GANAIE M A,ALHARTHY K M,et al.Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats[J].Arch Physiol Biochem,2020,126(4):300-307.
[11] WU N,YUAN T,YIN Z,et al.Network pharmacology and molecular docking study of the Chinese miao medicine sidaxue in the treatment of rheumatoid arthritis[J].Drug Des Devel Ther,2022,16(1):435-466.
[12] RADU A F,BUNGAU S G.Management of rheumatoid arthritis:an overview[J].Cells,2021,10(11):2857-2890.
[13] HUANG J,FU X,CHEN X,et al.Promising therapeutic targets for treatment of rheumatoid arthritis[J].Front Immunol,2021,12(1):1-23.
[14] YAO W,ZHANG X,XU F,et al.The therapeutic effects of naringenin on bronchial pneumonia in children[J].Pharmacol Res Perspect,2021,9(4):1-7.
[15] WRIGHT H L,LYON M,CHAPMAN E A,et al.Rheumatoid arthritis synovial fluid neutrophils drive inflammation through production of chemokines,reactive oxygen species,and neutrophil extracellular traps[J].Front Immunol,2021,11(1):1-14.
[16] WU C Y,YANG H Y,LUO S F,et al.From rheumatoid factor to anti-citrullinated protein antibodies and anti-carbamylated protein antibodies for diagnosis and prognosis prediction in patients with rheumatoid arthritis[J].Int J Mol Sci,2021,22(2):686-704.
[17] POPE J E,CHOY E H.C-reactive protein and implications in rheumatoid arthritis and associated comorbidities[J].Semin Arthritis Rheum,2021,51(1):219-229.
[18] DI Y,ZHANG M,CHEN Y,et al.Catalpol inhibits Tregs-to-Th17 cell transdifferentiation by up-regulating Let-7g-5p to reduce Stat3 protein levels[J].Yonsei Med J,2022,63(1):56-65.
[19] LEE G R.The balance of Th17 versus Treg cells in autoimmunity[J].Int J Mol Sci,2018,19(3):730-744.
[20] HU P,WANG M,GAO H,et al.The role of helper T cells in psoriasis[J].Front Immunol,2021,12(1):1-10. |